Balanced news tone
News Sentiment
688221 sentiment intelligence
Frontier Biotechnologies Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
62/100 classification confidence.
directly relevant articles
high-authority source matches
-23.3% over one week, +12.3% over four weeks, trend inactive, and materially above fair value.
ETFs Investing in Frontier Biotechnologies Inc. Class A Stocks
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
ETFs Investing in Frontier Biotechnologies Inc. Class A Stocks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jul 2026 07:15
- Source
- TradingView
GSK nabs two Frontier Biotech siRNA assets in $1B deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 25 Feb 2026 08:00
- Source
- BioWorld News
FRONTIER BIOTECHNOLOGIES ANNOUNCES POSITIVE PHASE 1 RESULTS OF ITS FIRST CORONAVIRUS MAIN PROTEASE (MPRO) SMALL MOLECULE INHIBITOR, LAYING FOUNDATION FOR THE TREATMENT OF ACUTE AND LONG COVID
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 08 Aug 2022 07:00
- Source
- PR Newswire
Frontier Biotechnologies' First Long-acting Injectable (Aikening(R)), in a Two Drug Regimen for HIV, Proves Safe and Efficacious for Patients
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jul 2021 07:00
- Source
- PR Newswire